• WDR36 Links Glycolysis to Trophectoderm Fate in Human Blasto

  2026-06-19

  This study identifies WDR36 as a key regulator of trophectoderm differentiation in human preimplantation embryo-like models, acting via modulation of glycolytic metabolism. These findings clarify how early lineage decisions can be metabolically governed and suggest new avenues for optimizing stem cell and embryology workflows.

• UTP Solution (100 mM): Precision Nucleotide for Epigenetic A

  2026-06-19

  Explore how UTP Solution (100 mM) empowers high-fidelity epigenetic and gene regulation studies. Delve into its unique role as a uridine-5'-triphosphate trisodium salt and discover assay insights unavailable in other articles.

• Puerarin Activates Nitric Oxide Pathway to Drive DFC Osteoge

  2026-06-18

  This study demonstrates that puerarin significantly enhances osteogenic differentiation in rat dental follicle cells (DFCs) by activating the nitric oxide signaling pathway. The findings reveal a mechanistic link between phytoestrogen action and NO-mediated tissue regeneration, with implications for periodontal therapy and regenerative medicine.

• Dextrose (D-glucose) in Glucose Metabolism Research Workflow

  2026-06-18

  Dextrose (D-glucose) is indispensable for dissecting metabolic reprogramming, immunometabolism, and cell viability under hypoxic and nutrient-limited conditions. Its unmatched solubility, purity, and performance enable reproducible data in advanced glucose metabolism research and troubleshooting of complex experimental systems.

• Rottlerin: A PKC Inhibitor Transforming Cell Proliferation S

  2026-06-17

  Rottlerin stands out as a selective PKCδ inhibitor, enabling precise modulation of cell proliferation and apoptosis in cancer and endothelial research. Its unique biochemical profile and compatibility with advanced assay workflows make it indispensable for researchers seeking robust, reproducible results.

• Berbamine Hydrochloride: Translating NF-κB Inhibition into H

  2026-06-17

  This thought-leadership article explores how Berbamine hydrochloride empowers translational cancer researchers to overcome ferroptosis resistance in hepatocellular carcinoma (HCC) by targeting the NF-κB signaling pathway. Integrating recent mechanistic breakthroughs, practical protocol guidance, and a critical assessment of current and emerging strategies, it charts actionable paths for experimental design and clinical translation.

• Partial BACE Inhibition Reduces Aβ Without Impairing Synapse

  2026-06-16

  Satir et al. demonstrated that partial β-secretase inhibition can lower amyloid beta generation by up to 50% without disrupting synaptic transmission in cultured neurons. This finding provides a nuanced perspective on Alzheimer's disease drug development, highlighting the importance of dose selection to balance efficacy and safety.

• U0126: Precision MEK1/2 Inhibition for Translational Progres

  2026-06-16

  Explore how U0126, a highly selective MEK1/2 inhibitor from APExBIO, enables translational researchers to dissect and modulate the MAPK/ERK pathway in complex disease models. By integrating mechanistic insights, real-world workflow strategies, and the latest neurodegeneration findings, this article offers actionable guidance for advancing experimental rigor and therapeutic discovery.

• Triamcinolone: Technical Guide for Synthetic Glucocorticoid

  2026-06-15

  Triamcinolone addresses the need for precise, reproducible modulation of glucocorticoid signaling pathways in cellular and molecular research. It is not suitable for diagnostic or clinical use and should be handled with strict adherence to solubility and storage requirements. This compound is intended for researchers studying anti-inflammatory or immunosuppressive mechanisms.

• Biomimetic Chromatography for Modeling Pulmonary Drug Permea

  2026-06-15

  This study benchmarks biomimetic open tubular capillary electrochromatography and immobilised artificial membrane chromatography, coupled with mass spectrometry, to predict pulmonary permeability of pharmaceuticals. The findings establish robust, high-throughput screening models that improve drug absorption predictions, guiding early-stage antiretroviral and translational research.

• Trelagliptin Enhances Osteoblastic Differentiation via RUNX2

  2026-06-14

  This study demonstrates that Trelagliptin, a DPP-4 inhibitor, promotes osteoblastic differentiation in MC3T3-E1 cells by upregulating RUNX2 through an AMPK-dependent mechanism. The findings highlight a potential new application for Trelagliptin in osteoporosis treatment and provide mechanistic insights relevant to bone biology research.

• CB-5083: Selective p97 Inhibitor for Protein Homeostasis Dis

  2026-06-13

  CB-5083 is a potent and orally bioavailable p97 inhibitor with an IC50 of 15.4 nM against wild-type p97, enabling targeted disruption of protein homeostasis in cancer models. Mechanistic and preclinical studies reveal robust tumor growth inhibition and apoptosis induction in xenograft models, positioning CB-5083 as a leading tool for oncological and protein degradation pathway research.

• Abiraterone Acetate as a CYP17 Inhibitor in Prostate Cancer

  2026-06-12

  Abiraterone acetate, a potent CYP17 inhibitor, enables precise androgen biosynthesis pathway modulation in advanced prostate cancer research. Innovative protocols using 3D patient-derived spheroid cultures unlock translational insights and model complexity that surpass conventional monolayer assays.

• Trifluoperazine 2HCl: Redefining Dopaminergic and Macrophage

  2026-06-12

  Explore how Trifluoperazine 2HCl, a potent dopamine D2 receptor inhibitor, uniquely bridges neuropharmacology and host-directed immunity. This article delivers advanced assay guidance and novel mechanistic insights, making it essential for researchers in neuroscience and immunology.

• Nystatin (Fungicidin) Workflows: Advanced Antifungal Researc

  2026-06-11

  Nystatin (Fungicidin) from APExBIO empowers researchers with robust, reproducible antifungal assays, directly targeting membrane integrity in Candida and Aspergillus species. This guide translates cutting-edge reference findings into actionable protocols, troubleshooting strategies, and optimized use-cases for resistance modeling and combination therapies.

421 records 12/29 page Previous Next First page 上5页 1112131415 下5页 Last page